Institutional Registry of Haemorrhagic Hereditary Telangiectasia

This registry collects clinical data from patients with Hereditary Hemorrhagic Telangiectasia (HHT) — a genetic disorder that causes abnormal blood vessel formation, leading to nosebleeds, GI bleeding, and potentially dangerous vessel malformations in organs like the lungs, liver, and brain. The goal is to improve understanding and management of this rare condition. You may be eligible if: - You have a confirmed diagnosis of HHT - You are currently being followed at the HHT Unit of Hospital Italiano de Buenos Aires You may NOT be eligible if: - You declined to participate or to go through the informed consent process Talk to your doctor to see if this trial is right for you.